Michael E. Solomon founded Epizyme, Inc. Currently, Dr. Solomon is Chief Executive Officer & Director at Ribometrix, Inc.
He is also on the board of Protara Therapeutics, Inc. and ValenzaBio, Inc.
In his past career he held the position of Chief Operating Officer for Decibel Therapeutics, Inc., Vice President-Discovery at Epizyme, Inc., Chief Operating Officer for Ember Therapeutics, Inc., Principal at Millennium Pharmaceuticals, Inc., Vice President-Discovery at Hypnion, Inc., Chief Business Officer for Link Medicine Corp., Senior Associate at Banc of America Securities LLC and Venture Capital at SV Health Investors LLC.
He received an undergraduate degree from the University of Massachusetts and a doctorate from the University of Wisconsin.